Target intelligence / Profile preview

Calmodulin 1 pseudogene (None commonly recognized; the abbreviation "CALM1 pseudogene" is used informally but not standardized)

Target: None commonly recognized; the abbreviation "CALM1 pseudogene" is used informally but not standardized
Molecular classification: Pseudogene, Non-coding DNA element, Processed pseudogene

Overview

Calmodulin 1 pseudogene (ENSG00000270797) is a DNA sequence that closely resembles the functional CALM1 gene but is incapable of producing a functional calmodulin protein due to disruptions in its coding region (e.g., mutations, lack of introns). It is not transcribed into a functional product and does not participate directly in cellular signaling or serve as a molecular target. Such pseudogenes, while occasionally studied for potential regulatory RNA roles, have no recognized role in disease or therapeutic intervention at present.

Other names: Calmodulin 1 pseudogeneCALM1 pseudogeneCalmodulin 1 (Phosphorylase Kinase, Delta) pseudogene

Mechanism of action

None relevant for the pseudogene. Mechanisms (e.g., calcium signaling modulation) apply to calmodulin 1 protein, not pseudogene

Biological functions

None established for the pseudogene itself. The canonical gene codes a calcium-binding protein involved in signal transduction, but the pseudogene lacks a functional product

Disease associations

None established for the pseudogene itself. Disease associations (e.g., cardiac arrhythmias, long QT syndrome) pertain to the functional CALM1 gene, not its pseudogene

Safety considerations

None, since no therapeutic targeting or biological activity is known for this pseudogene.

Interacting drugs

None. Drugs target the calmodulin protein, not its pseudogene sequence

Biomarkers

None known. Pseudogenes are not established biomarkers for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Calmodulin 1 pseudogene (None commonly recognized; the abbreviation "CALM1 pseudogene" is used informally but not standardized).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmodulin 1 pseudogene (None commonly recognized; the abbreviation "CALM1 pseudogene" is used informally but not standardized).

Explore the full profile